发明名称 Prostata cellelinier og deres anvendelse
摘要 An increasingly aged population and better diagnosis has lead to an apparent increase in the prevalence of prostate cancer in men. There is an acute need to better understand the progression of this disease from its locally confined site of initiation to the end stage widely metastatic disease with attendant morbidity and mortality, It has historically been difficult to raise and maintain immortalized prostate cell lines in culture. We have derived a cell line selected from the group consisting of clones ONYCAP 1 and ONYCAP23. The cell lines are characterized as being prostate epithelial in origin.
申请公布号 DK1272617(T3) 申请公布日期 2011.08.22
申请号 DK20010917257T 申请日期 2001.03.30
申请人 ONYVAX LIMITED 发明人 THRAVES, PETER;SUTTON, ANDREW O
分类号 C12N5/09;A61K39/00;A61P35/00 主分类号 C12N5/09
代理机构 代理人
主权项
地址